Table 1

GWAS, replication and meta-analysis results for loci reaching P < 10−6 in the discovery GWAS

Discovery stage
Replication
Meta-analysis
Meta-analysis with DKD adjustmenta
SNPChr:Pos_REF/ALTGeneEAFOR (95% CI)P-valueRSQNPowerP-valueDirOR (95% CI)P-valueOR (95% CI)P-value
rs19701129:22085598_T/CCDKN2B-AS10.411.32 (1.2–1.46)1.50 × 10−80.98434/31230.460.09+ +++1.27 (1.17–1.38)1.19 × 10−81.28 (1.18–1.39)1.91 × 10−9
rs1811764932:224157866_G/ATRK-TTT15-1(pseudo)*, KCNE40.013.88 (2.33–6.47)1.98 × 10−70.80+ ???3.88 (2.33–6.47)1.98 × 10−73.62 (2.19–5.98)4.91 × 10−7
rs709627662:62406999_ CTTTTTTTTTTTT/CRPSA26(pseudo)*, B3GNT2*0.990.2 (0.11–0.37)4.68 × 10−70.64− ???0.2 (0.11–0.37)4.68 × 10−70.47 (0.29–0.75)0.0017
rs1381815786:45725830_A/ATLOC107986519, CLIC50.990.18 (0.09–0.35)6.78 × 10−70.77− ???0.18 (0.09–0.35)6.78 × 10−70.36 (0.22–0.60)8.33 × 10−5
rs1062578411:106193897_T/TAAALOC643855*, AASDHPPT0.990.23 (0.13–0.42)7.63 × 10−70.83− ???0.23 (0.13–0.42)7.63 × 10−70.44 (0.28–0.70)0.00045
rs7923770015:53741612_T/CLOC105370826, WDR72*0.041.97 (1.51–2.55)3.86 × 10−70.75237/6320.170.79+ −??1.82 (1.42–2.33)2.23 × 10−61.76 (1.37–2.25)6.88 × 10−6
rs5744807795:154390880_TA/TKIF4B0.032.27 (1.64–3.15)9.36 × 10−70.69+ ???2.27 (1.64–3.15)9.36 × 10−72.14 (1.56–2.95)2.91 × 10−6
rs13442282:124286924_C/TLOC100422580, CNTNAP50.111.46 (1.26–1.69)5.64 × 10−71.00434/31230.330.71+ −++1.33 (1.17–1.51)8.68 × 10−61.33 (1.17–1.50)8.30 × 10−6
rs605506920:134284_T/CDEFB1270.980.24 (0.15–0.38)2.35 × 10−90.62322/19170.950.74− +?−0.38 (0.25–0.56)1.36 × 10−60.49 (0.35–0.70)9.80 × 10−5
rs21124815:125691632_T/GGRAMD2B0.990.10 (0.04–0.23)6.98 × 10−80.63434/312310.35− +−+0.67 (0.43–1.01)0.0580.73 (0.50–1.06)0.097
Discovery stage
Replication
Meta-analysis
Meta-analysis with DKD adjustmenta
SNPChr:Pos_REF/ALTGeneEAFOR (95% CI)P-valueRSQNPowerP-valueDirOR (95% CI)P-valueOR (95% CI)P-value
rs19701129:22085598_T/CCDKN2B-AS10.411.32 (1.2–1.46)1.50 × 10−80.98434/31230.460.09+ +++1.27 (1.17–1.38)1.19 × 10−81.28 (1.18–1.39)1.91 × 10−9
rs1811764932:224157866_G/ATRK-TTT15-1(pseudo)*, KCNE40.013.88 (2.33–6.47)1.98 × 10−70.80+ ???3.88 (2.33–6.47)1.98 × 10−73.62 (2.19–5.98)4.91 × 10−7
rs709627662:62406999_ CTTTTTTTTTTTT/CRPSA26(pseudo)*, B3GNT2*0.990.2 (0.11–0.37)4.68 × 10−70.64− ???0.2 (0.11–0.37)4.68 × 10−70.47 (0.29–0.75)0.0017
rs1381815786:45725830_A/ATLOC107986519, CLIC50.990.18 (0.09–0.35)6.78 × 10−70.77− ???0.18 (0.09–0.35)6.78 × 10−70.36 (0.22–0.60)8.33 × 10−5
rs1062578411:106193897_T/TAAALOC643855*, AASDHPPT0.990.23 (0.13–0.42)7.63 × 10−70.83− ???0.23 (0.13–0.42)7.63 × 10−70.44 (0.28–0.70)0.00045
rs7923770015:53741612_T/CLOC105370826, WDR72*0.041.97 (1.51–2.55)3.86 × 10−70.75237/6320.170.79+ −??1.82 (1.42–2.33)2.23 × 10−61.76 (1.37–2.25)6.88 × 10−6
rs5744807795:154390880_TA/TKIF4B0.032.27 (1.64–3.15)9.36 × 10−70.69+ ???2.27 (1.64–3.15)9.36 × 10−72.14 (1.56–2.95)2.91 × 10−6
rs13442282:124286924_C/TLOC100422580, CNTNAP50.111.46 (1.26–1.69)5.64 × 10−71.00434/31230.330.71+ −++1.33 (1.17–1.51)8.68 × 10−61.33 (1.17–1.50)8.30 × 10−6
rs605506920:134284_T/CDEFB1270.980.24 (0.15–0.38)2.35 × 10−90.62322/19170.950.74− +?−0.38 (0.25–0.56)1.36 × 10−60.49 (0.35–0.70)9.80 × 10−5
rs21124815:125691632_T/GGRAMD2B0.990.10 (0.04–0.23)6.98 × 10−80.63434/312310.35− +−+0.67 (0.43–1.01)0.0580.73 (0.50–1.06)0.097

−, protection; ?, data not available; +, predisposition; Chr:Pos_REF/ALT, chromosome and base pair position, reference/alternative (=non-effect/effect) allele; Dir, effect direction (for effect i.e. alternative allele) in FinnDiane, SDCC, UK-ROI, and French; EAF, effect (alternative) allele frequency; Gene, closest gene(s) underlying or within the promoter region (5kbp upstream), or *within ±50kbp, within ±250kbp, or within ±500kbp; N, Ncases/controls in replication; OR (95% CI), odds ratio and 95% confidence interval; Power, statistical power to observe association with α = 0.05/5 = 0.01 significance level, based on discovery study EAF and 95% lower CI of OR, and 12.2%, 27.3%, or 14.4% CAD prevalence in corresponding replication cohort; RSQ, imputation r2 quality estimate.

a

NFinnDaine = 926/3777 in meta-analysis with DKD.

Table 1

GWAS, replication and meta-analysis results for loci reaching P < 10−6 in the discovery GWAS

Discovery stage
Replication
Meta-analysis
Meta-analysis with DKD adjustmenta
SNPChr:Pos_REF/ALTGeneEAFOR (95% CI)P-valueRSQNPowerP-valueDirOR (95% CI)P-valueOR (95% CI)P-value
rs19701129:22085598_T/CCDKN2B-AS10.411.32 (1.2–1.46)1.50 × 10−80.98434/31230.460.09+ +++1.27 (1.17–1.38)1.19 × 10−81.28 (1.18–1.39)1.91 × 10−9
rs1811764932:224157866_G/ATRK-TTT15-1(pseudo)*, KCNE40.013.88 (2.33–6.47)1.98 × 10−70.80+ ???3.88 (2.33–6.47)1.98 × 10−73.62 (2.19–5.98)4.91 × 10−7
rs709627662:62406999_ CTTTTTTTTTTTT/CRPSA26(pseudo)*, B3GNT2*0.990.2 (0.11–0.37)4.68 × 10−70.64− ???0.2 (0.11–0.37)4.68 × 10−70.47 (0.29–0.75)0.0017
rs1381815786:45725830_A/ATLOC107986519, CLIC50.990.18 (0.09–0.35)6.78 × 10−70.77− ???0.18 (0.09–0.35)6.78 × 10−70.36 (0.22–0.60)8.33 × 10−5
rs1062578411:106193897_T/TAAALOC643855*, AASDHPPT0.990.23 (0.13–0.42)7.63 × 10−70.83− ???0.23 (0.13–0.42)7.63 × 10−70.44 (0.28–0.70)0.00045
rs7923770015:53741612_T/CLOC105370826, WDR72*0.041.97 (1.51–2.55)3.86 × 10−70.75237/6320.170.79+ −??1.82 (1.42–2.33)2.23 × 10−61.76 (1.37–2.25)6.88 × 10−6
rs5744807795:154390880_TA/TKIF4B0.032.27 (1.64–3.15)9.36 × 10−70.69+ ???2.27 (1.64–3.15)9.36 × 10−72.14 (1.56–2.95)2.91 × 10−6
rs13442282:124286924_C/TLOC100422580, CNTNAP50.111.46 (1.26–1.69)5.64 × 10−71.00434/31230.330.71+ −++1.33 (1.17–1.51)8.68 × 10−61.33 (1.17–1.50)8.30 × 10−6
rs605506920:134284_T/CDEFB1270.980.24 (0.15–0.38)2.35 × 10−90.62322/19170.950.74− +?−0.38 (0.25–0.56)1.36 × 10−60.49 (0.35–0.70)9.80 × 10−5
rs21124815:125691632_T/GGRAMD2B0.990.10 (0.04–0.23)6.98 × 10−80.63434/312310.35− +−+0.67 (0.43–1.01)0.0580.73 (0.50–1.06)0.097
Discovery stage
Replication
Meta-analysis
Meta-analysis with DKD adjustmenta
SNPChr:Pos_REF/ALTGeneEAFOR (95% CI)P-valueRSQNPowerP-valueDirOR (95% CI)P-valueOR (95% CI)P-value
rs19701129:22085598_T/CCDKN2B-AS10.411.32 (1.2–1.46)1.50 × 10−80.98434/31230.460.09+ +++1.27 (1.17–1.38)1.19 × 10−81.28 (1.18–1.39)1.91 × 10−9
rs1811764932:224157866_G/ATRK-TTT15-1(pseudo)*, KCNE40.013.88 (2.33–6.47)1.98 × 10−70.80+ ???3.88 (2.33–6.47)1.98 × 10−73.62 (2.19–5.98)4.91 × 10−7
rs709627662:62406999_ CTTTTTTTTTTTT/CRPSA26(pseudo)*, B3GNT2*0.990.2 (0.11–0.37)4.68 × 10−70.64− ???0.2 (0.11–0.37)4.68 × 10−70.47 (0.29–0.75)0.0017
rs1381815786:45725830_A/ATLOC107986519, CLIC50.990.18 (0.09–0.35)6.78 × 10−70.77− ???0.18 (0.09–0.35)6.78 × 10−70.36 (0.22–0.60)8.33 × 10−5
rs1062578411:106193897_T/TAAALOC643855*, AASDHPPT0.990.23 (0.13–0.42)7.63 × 10−70.83− ???0.23 (0.13–0.42)7.63 × 10−70.44 (0.28–0.70)0.00045
rs7923770015:53741612_T/CLOC105370826, WDR72*0.041.97 (1.51–2.55)3.86 × 10−70.75237/6320.170.79+ −??1.82 (1.42–2.33)2.23 × 10−61.76 (1.37–2.25)6.88 × 10−6
rs5744807795:154390880_TA/TKIF4B0.032.27 (1.64–3.15)9.36 × 10−70.69+ ???2.27 (1.64–3.15)9.36 × 10−72.14 (1.56–2.95)2.91 × 10−6
rs13442282:124286924_C/TLOC100422580, CNTNAP50.111.46 (1.26–1.69)5.64 × 10−71.00434/31230.330.71+ −++1.33 (1.17–1.51)8.68 × 10−61.33 (1.17–1.50)8.30 × 10−6
rs605506920:134284_T/CDEFB1270.980.24 (0.15–0.38)2.35 × 10−90.62322/19170.950.74− +?−0.38 (0.25–0.56)1.36 × 10−60.49 (0.35–0.70)9.80 × 10−5
rs21124815:125691632_T/GGRAMD2B0.990.10 (0.04–0.23)6.98 × 10−80.63434/312310.35− +−+0.67 (0.43–1.01)0.0580.73 (0.50–1.06)0.097

−, protection; ?, data not available; +, predisposition; Chr:Pos_REF/ALT, chromosome and base pair position, reference/alternative (=non-effect/effect) allele; Dir, effect direction (for effect i.e. alternative allele) in FinnDiane, SDCC, UK-ROI, and French; EAF, effect (alternative) allele frequency; Gene, closest gene(s) underlying or within the promoter region (5kbp upstream), or *within ±50kbp, within ±250kbp, or within ±500kbp; N, Ncases/controls in replication; OR (95% CI), odds ratio and 95% confidence interval; Power, statistical power to observe association with α = 0.05/5 = 0.01 significance level, based on discovery study EAF and 95% lower CI of OR, and 12.2%, 27.3%, or 14.4% CAD prevalence in corresponding replication cohort; RSQ, imputation r2 quality estimate.

a

NFinnDaine = 926/3777 in meta-analysis with DKD.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close